Navidea Biopharmaceuticals, Inc. (NAVBQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Jan 22, 2026
NAVBQ Market Cap
NAVBQ has a market cap or net worth of $100 as of January 23, 2026. Its market cap has decreased by -99.90% in one year.
Market Cap
100.00
Enterprise Value
n/a
Revenue
610.00
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 10, 1992, NAVBQ's market cap has decreased from 4.93M to 100.00, a decrease of -100.00%. That is a compound annual growth rate of -27.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 100.00 | - |
| Dec 31, 2025 | 100.00 | -99.00% |
| Dec 31, 2024 | 10.00K | -99.82% |
| Dec 29, 2023 | 5.52M | -18.56% |
| Dec 30, 2022 | 6.78M | -77.52% |
| Dec 31, 2021 | 30.15M | -47.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Virpax Pharmaceuticals | 13.79K |
| Vaxxinity | 12.68K |
| PaxMedica | 12.63K |
| ObsEva | 11.72K |
| Trevena | 10.64K |
| GeneLink | 10.60K |
| Biostax | 10.52K |
| Entia Biosciences | 10.22K |